How severe is CVE-2024-6182?

CVE-2024-6182 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.

Is CVE-2024-6182 being actively exploited?

It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.

What products are affected by CVE-2024-6182?

CVE-2024-6182 affects Labvantage Labvantage Lims. See the affected-products list for the exact vulnerable versions.

How do I fix CVE-2024-6182?

Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.

Does CVE-2024-6182 have an EU (EUVD) identifier?

Yes. CVE-2024-6182 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-47321.

When was CVE-2024-6182 published?

CVE-2024-6182 was published on 2024-06-20 and last updated on 2026-06-17.

CVE-2024-6182

CVE-2024-6182 is a low-severity vulnerability in Labvantage Labvantage Lims with a CVSS 3.x base score of 3.5. It is not currently listed as actively exploited by CISA, and its EPSS exploit-prediction score is low. The underlying weakness is classified as CWE-79.

Key facts

Severity: Low (CVSS 3.x base score 3.5)
CVSS v2: 4.0
CVSS v4: 5.3
EPSS exploit prediction: 0% (36th percentile)
Actively exploited: Not listed in CISA KEV
EU (EUVD) id: EUVD-2024-47321
Weakness: CWE-79
Affected product: Labvantage Labvantage Lims
Published: 2024-06-20
Last modified: 2026-06-17

Description

A vulnerability was found in LabVantage LIMS 2017. It has been rated as problematic. This issue affects some unknown processing of the file /labvantage/rc?command=page&page=LV_ViewSampleSpec&oosonly=Y&_sdialog=Y. The manipulation of the argument sdcid/keyid1 leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-269153 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.

Frequently asked questions

What is CVE-2024-6182?: A vulnerability was found in LabVantage LIMS 2017. It has been rated as problematic. This issue affects some unknown processing of the file /labvantage/rc?command=page&page=LV_ViewSampleSpec&oosonly=Y&_sdialog=Y. The manipulation of the argument sdcid/keyid1 leads to cross site scripting. The attack may be initiated remotely. The exploit has been disclosed to the public and may be used. The identifier VDB-269153 was assigned to this vulnerability. NOTE: The vendor was contacted early about this disclosure but did not respond in any way.
How severe is CVE-2024-6182?: CVE-2024-6182 has a CVSS 3.x base score of 3.5, rated low severity. It is exploitable over network with low attack complexity, requires low privileges and user interaction. Impact on confidentiality is none, integrity low, and availability none.
Is CVE-2024-6182 being actively exploited?: It is not currently listed in CISA's KEV catalog. Its EPSS exploit-prediction score is 0% (36th percentile), an estimate of the probability of exploitation in the next 30 days.
What products are affected by CVE-2024-6182?: CVE-2024-6182 affects Labvantage Labvantage Lims. See the affected-products list for the exact vulnerable versions.
How do I fix CVE-2024-6182?: Review the linked vendor and NVD advisories for patched versions and mitigations, then upgrade or apply the recommended workaround.
Does CVE-2024-6182 have an EU (EUVD) identifier?: Yes. CVE-2024-6182 is tracked in the ENISA EU Vulnerability Database (EUVD) as EUVD-2024-47321.
When was CVE-2024-6182 published?: CVE-2024-6182 was published on 2024-06-20 and last updated on 2026-06-17.

References

Affected products (1)

cpe:2.3:a:labvantage:labvantage_lims:2017:*:*:*:*:*:*:*

More vulnerabilities in Labvantage Labvantage Lims

CVE-2024-6181 — Low (CVSS 3.5): A vulnerability was found in LabVantage LIMS 2017. It has been declared as problematic. This vulnerability affects…

All CVEs affecting Labvantage Labvantage Lims →

Other CWE-79 (Cross-site Scripting (XSS)) vulnerabilities

CVE-2025-49410 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation ('Cross-site Scripting') vulnerability in Imran Emu TC…
CVE-2024-47875 — Critical (CVSS 10.0): DOMPurify is a DOM-only, super-fast, uber-tolerant XSS sanitizer for HTML, MathML and SVG. DOMpurify was vulnerable to…
CVE-2024-6886 — Critical (CVSS 10.0): Improper Neutralization of Input During Web Page Generation (XSS or 'Cross-site Scripting') vulnerability in Gitea…
CVE-2023-45144 — Critical (CVSS 10.0): com.xwiki.identity-oauth:identity-oauth-ui is a package to aid in building identity and service providers based on…
CVE-2023-45138 — Critical (CVSS 10.0): Change Request is an pplication allowing users to request changes on a wiki without publishing the changes directly.…
CVE-2022-4361 — Critical (CVSS 10.0): Keycloak, an open-source identity and access management solution, has a cross-site scripting (XSS) vulnerability in the…

Browse all CWE-79 (Cross-site Scripting (XSS)) vulnerabilities →